Literature DB >> 17218792

Effects of intrathecal injection of T-type calcium channel blockers in the rat formalin test.

Jen-Kun Cheng1, Chia-Shiang Lin, Chien-Chuan Chen, Jia-Rung Yang, Lih-Chu Chiou.   

Abstract

T-type Ca2+ channels have been implicated in the induction of long-term potentiation, a synaptic plasticity involved in the central sensitization that contributes to the generation of inflammatory pain, in spinal sensory neurons. In this study, we examined the effects of intrathecal T-type Ca2+ channel blockers, mibefradil, ethosuximide and NiCl2, in the rat formalin test, an inflammatory pain model. Biphasic characteristic nociceptive behaviors were induced by intraplantar injection of formalin (5% formaldehyde, 50 microl) in Sprague-Dawley rats and monitored at 0-9 min (phase 1) and 10-60 min (phase 2) after formalin injection. Intrathecal pretreatment with mibefradil (50-500 microg) and NiCl2 (1-10 microg) dose-dependently decreased the flinch numbers and biting and licking time in both phases. The ID50s of mibefradil in inhibiting the phases 1 and 2 flinch responses were 74.3+/-4.6 and 100.9+/-8.7 microg, respectively, and those of NiCl2 were 2.7+/-1.1 and 3.3+/-0.1 microg, respectively. Ethosuximide, at the doses up to 1200 microg, however, did not affect the nociceptive responses in both phases. It is suggested that spinal T-type Ca2+ channels may play a role in formalin-induced inflammatory pain. The ineffectiveness of ethosuximide is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17218792     DOI: 10.1097/FBP.0b013e3280141375

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  9 in total

Review 1.  Recent advances in the development of T-type calcium channel blockers for pain intervention.

Authors:  Terrance P Snutch; Gerald W Zamponi
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

2.  Characterisation of rebound depolarisation in mice deep dorsal horn neurons in vitro.

Authors:  Ivan Rivera-Arconada; Jose A Lopez-Garcia
Journal:  Pflugers Arch       Date:  2014-10-09       Impact factor: 3.657

3.  Regulation of spinal substance p release by intrathecal calcium channel blockade.

Authors:  Toshifumi Takasusuki; Tony L Yaksh
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

4.  ERK, synaptic plasticity and acid-induced muscle pain.

Authors:  Ming-Yuan Min; Hsiu-Wen Yang; Chen-Tung Yen; Chien-Chang Chen; Chih-Cheng Chen; Sin-Jhong Cheng
Journal:  Commun Integr Biol       Date:  2011-07-01

Review 5.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

6.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

Review 7.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases.

Authors:  Gerald W Zamponi
Journal:  Nat Rev Drug Discov       Date:  2015-11-06       Impact factor: 84.694

Review 8.  Central and peripheral contributions of T-type calcium channels in pain.

Authors:  Erika K Harding; Gerald W Zamponi
Journal:  Mol Brain       Date:  2022-05-02       Impact factor: 4.399

9.  NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.

Authors:  N Daniel Berger; Vinicius M Gadotti; Ravil R Petrov; Kevin Chapman; Philippe Diaz; Gerald W Zamponi
Journal:  Mol Pain       Date:  2014-12-06       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.